Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.
2.

A multicenter study to validate the reproducibility of MSI testing with a panel of 5 quasimonomorphic mononucleotide repeats.

Nardon E, Glavač D, Benhattar J, Groenen PJ, Höfler G, Höfler H, Jung A, Keller G, Kirchner T, Lessi F, Ligtenberg MJ, Mazzanti CM, Winter G, Stanta G.

Diagn Mol Pathol. 2010 Dec;19(4):236-42. doi: 10.1097/PDM.0b013e3181db67af.

PMID:
21051996
3.

Hereditary pancreatic cancer.

Grover S, Syngal S.

Gastroenterology. 2010 Oct;139(4):1076-80, 1080.e1-2. doi: 10.1053/j.gastro.2010.08.012. Epub 2010 Aug 19. Review. No abstract available.

4.

Risk of pancreatic cancer in families with Lynch syndrome.

Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S.

JAMA. 2009 Oct 28;302(16):1790-5. doi: 10.1001/jama.2009.1529.

5.

Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.

Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J, Kloeppel G, Sessa F, Edmonston TB, Schneider-Stock R, Klinkhammer-Schalke M, Pauer A, Schick S, Hofstaedter F, Baumhoer D, Hartmann A.

Am J Surg Pathol. 2009 May;33(5):691-704. doi: 10.1097/PAS.0b013e3181983ef7.

PMID:
19252434
6.

Differences and evolution of the methods for the assessment of microsatellite instability.

Laghi L, Bianchi P, Malesci A.

Oncogene. 2008 Oct 23;27(49):6313-21. doi: 10.1038/onc.2008.217. Epub 2008 Aug 4. Review.

PMID:
18679418
7.

Tumor-node-metastasis staging of pancreatic adenocarcinoma.

Katz MH, Hwang R, Fleming JB, Evans DB.

CA Cancer J Clin. 2008 Mar-Apr;58(2):111-25. doi: 10.3322/CA.2007.0012. Epub 2008 Feb 13. Review.

8.

Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ, Fisher S, Hodgson SV.

Fam Cancer. 2008;7(2):163-72. Epub 2007 Oct 16.

PMID:
17939062
9.

Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.

Malesci A, Laghi L, Bianchi P, Delconte G, Randolph A, Torri V, Carnaghi C, Doci R, Rosati R, Montorsi M, Roncalli M, Gennari L, Santoro A.

Clin Cancer Res. 2007 Jul 1;13(13):3831-9.

10.

Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.

Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):546-52.

11.

Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.

Xicola RM, Llor X, Pons E, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Duque JM, Nicolás-Pérez D, Garcia AM, Rigau J, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

J Natl Cancer Inst. 2007 Feb 7;99(3):244-52.

12.

Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.

Banville N, Geraghty R, Fox E, Leahy DT, Green A, Keegan D, Geoghegan J, O'Donoghue D, Hyland J, Sheahan K.

Hum Pathol. 2006 Nov;37(11):1498-502. Epub 2006 Sep 25.

PMID:
16996571
13.

Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.

Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E, Franchi G, Morenghi E, Laghi L, Gennari L, Roncalli M.

Br J Cancer. 2006 Oct 23;95(8):1101-7. Epub 2006 Sep 12.

14.

Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes.

Immervoll H, Hoem D, Kugarajh K, Steine SJ, Molven A.

Virchows Arch. 2006 Jun;448(6):788-96. Epub 2006 Apr 6.

PMID:
16598499
15.

Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer.

Maple JT, Smyrk TC, Boardman LA, Johnson RA, Thibodeau SN, Chari ST.

Pancreatology. 2005;5(2-3):220-7; discussion 227-8. Epub 2005 Apr 22.

PMID:
15855819
16.

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G, Haglund C.

Gut. 2005 Mar;54(3):385-7.

17.

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.

Calhoun ES, Jones JB, Ashfaq R, Adsay V, Baker SJ, Valentine V, Hempen PM, Hilgers W, Yeo CJ, Hruban RH, Kern SE.

Am J Pathol. 2003 Oct;163(4):1255-60.

19.

Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR.

Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, Leroy K, Seruca R, Iacopetta B, Hamelin R.

Gastroenterology. 2002 Dec;123(6):1804-11.

PMID:
12454837
20.

Prognostic value of microsatellite instability in resectable pancreatic cancer.

Nakata B, Wang YQ, Yashiro M, Nishioka N, Tanaka H, Ohira M, Ishikawa T, Nishino H, Hirakawa K.

Clin Cancer Res. 2002 Aug;8(8):2536-40.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk